| Michael S Serwint, MD | |
|
365 Brookdale Dr, Statesville, NC 28677 | |
| (704) 872-3630 | |
| (704) 872-0049 |
| Full Name | Michael S Serwint |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 365 Brookdale Dr, Statesville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578544821 | NPI | - | NPPES |
| 89131J5 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael S Serwint, MD 365 Brookdale Dr, Statesville, NC 28677-4108 Ph: (704) 872-3630 | Michael S Serwint, MD 365 Brookdale Dr, Statesville, NC 28677 Ph: (704) 872-3630 |
News Archive
Baxter International Inc. today announced the approval of ADVATE [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with hemophilia A (congenital factor VIII deficiency) in China by the State Food and Drug Administration.
Persistent use of cannabis before the age of 18 years can lead to lowered intelligence, attention, and memory in adulthood, show results published in the Proceedings of the National Academy of Sciences.
Despite it being more than 30 years since the "fountain of youth drug" Gerovital H3 was banned in the United States, it may be making a comeback. In an editorial published in this month's Journal of the American Geriatrics Society BUSM researcher Thomas Perls, MD, points out that a few U.S.-based anti-aging and longevity clinics have begun to advertise Gerovital H3 in pill form and as intravenous infusions despite the fact that the U.S. Food and Drug Administration banned it in 1982.
Novozymes Biopharma has entered a new collaborative research agreement with one of the world's top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis technology, to assess the dosing and performance of a novel subunit antigen vaccine candidate.
› Verified 6 days ago
Ms. Virginia Fredericka Wright, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1022 Shelton Ave, Statesville, NC 28677 Phone: 704-838-1234 Fax: 704-768-2081 | |
Jose Eduardo Perez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 208 Old Mocksville Rd, Statesville, NC 28625 Phone: 704-838-8240 Fax: 704-384-5360 | |
Dr. Nasib Ayoubi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 770 Hartness Rd, Statesville, NC 28677 Phone: 704-872-6810 | |
Elias David Ruiz Valdez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 557 Brookdale Dr, Statesville, NC 28677 Phone: 704-873-5661 | |
Neil M Kassman, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 208 Old Mocksville Rd, Statesville, NC 28625 Phone: 704-838-8215 | |
Dr. Robert Adjamah Aryeetey, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 276 Old Mocksville Road, Suite 1100, Statesville, NC 28625 Phone: 704-878-2523 Fax: 704-878-6417 | |
Dr. James Hedrick Bradford, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 738 Bryant St, Suite A, Statesville, NC 28677 Phone: 704-873-1180 Fax: 704-873-1116 |